The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
about
Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naïve Population.Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.Cholera: Immunity and Prospects in Vaccine Development
P2860
The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The Live Attenuated Cholera Va ...... ith Wild-Type Vibrio cholerae.
@en
The Live Attenuated Cholera Va ...... ith Wild-Type Vibrio cholerae.
@nl
type
label
The Live Attenuated Cholera Va ...... ith Wild-Type Vibrio cholerae.
@en
The Live Attenuated Cholera Va ...... ith Wild-Type Vibrio cholerae.
@nl
prefLabel
The Live Attenuated Cholera Va ...... ith Wild-Type Vibrio cholerae.
@en
The Live Attenuated Cholera Va ...... ith Wild-Type Vibrio cholerae.
@nl
P2093
P2860
P921
P356
P1476
The Live Attenuated Cholera Va ...... ith Wild-Type Vibrio cholerae.
@en
P2093
Beth D Kirkpatrick
Caroline E Lyon
Douglas Haney
Jakub K Simon
Jason B Harris
Leslie M Mayo-Smith
Marc Gurwith
Michael Lock
Mitchell Cohen
Stephen B Calderwood
P2860
P356
10.1128/CVI.00470-16
P577
2016-11-09T00:00:00Z